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1. Introduction 
In previous reports [l-6] we have described the 
coupling of a number of enzymes to cyanogen 
bromide-activated dextran to produce soluble enzyme- 
dextran conjugates. Enzymes modified in this way 
have stability properties that are superior to those of 
the corresponding native enzymes. Thus conjugation 
of catalase, OL- and (3-amylases, and trypsin with dextran 
decreased their susceptibility to heat inactivation 
[l-5] . Following conjugation, the stability of trypsin 
in the presence of protein denaturants such as urea 
and sodium dodecyl sulfate was markedly increased, 
and the enzyme became resistant to inhibition by 
naturally-occurring protease inhibitors [2,3] . Enzyme- 
dextran conjugates were also shown to be more resis- 
tant than the corresponding native enzymes to 
proteolytic inactivation, both autolytic [2,3] and by 
added exogenous proteases [5] . We have now investi- 
gated the behavior of two synthetic enzyme-dextran 
conjugates in experimental animals with a view to 
determining whether enzymes modified by attach- 
ment of carbohydrate are likely to have properties 
making them more useful than unmodified enzymes 
for the therapy of metabolic disorders that are 
responsive to administration of exogenous enzymes. 
In this report the effect of attachment of dextran on 
the in vivo behavior of Bacillus arnyloliquefaciens 
cu-amylase and bovine liver catalase is described. Our 
findings suggest a new approach to increasing the 
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duration of therapeutic usefulness of certain enzymes 
used for treatment of metabolic disorders. A prelimi- 
nary account of this work has been published [7] . 
2. Materials and methods 
cY-Amylase (1,4-o-D-glucan glucanohydrolase, 
EC 3.2.1 .l .) was a 4-times crystallized preparation 
from Bacillus amyloliquefaciens supplied by Sigma 
Chemical Company, St. Louis, MO (sold as Bacillus 
subtilis cY-amylase). Beef liver catalase (hydrogen 
peroxide : hydrogen peroxide oxidoreductase, 
EC 1 .l 1 .1.6) was also from Sigma. Dextrans (av. mol. 
wt approx. lo6 and 60 000-90 000) were from 
Fisons Ltd. (Loughborough, England) and Sigma, 
respectively. 
ol-Amylase activities were determined by measuring 
the rate of release of reducing sugars from soluble 
starch at 37°C and pH 5.5, using a copper reducing 
power method [8] . During the determination of 
a-amylase activities in blood samples, deproteiniza- 
tion of enzyme digests using barium hydroxide and 
zinc sulfate [9] was necessary prior to measurement 
of reducing sugars released by enzyme action. One 
unit (U) of cu-amylase activity is the amount that 
releases 1 ~01 reducing sugars/mm from soluble 
starch under the above conditions. Specific activities 
are expressed as U/mg protein. 
Catalase activity was measured spectrophoto- 
metrically [lo] . Digests (3.0 ml) contained hydrogen 
peroxide (2.9 ml 11.8 mM hydrogen peroxide solution 
in 0.05 M phosphate buffer, pH 7.0) and 0.1 ml suit- 
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ably diluted enzyme solution. The time taken for the 
absorbance of the mixture to decrease from 0.45-0.40 
(i.e., from a hydrogen peroxide concentration of 
10.3-9.2 mM) was measured and used to calculate 
enzyme activity. One unit (U) of catalase brings about 
the decomposition of 1 lrnol hydrogen peroxide/min 
at 25°C. Specific activities are expressed as U/mg 
protein. 
Soluble conjugates of cu-amylase and catalase with 
dextran (mol. wt IO6 and 60 000-90 000, respec- 
tively) were prepared by treatment of the polysaccha- 
ride under carefully controlled conditions with cyan- 
ogen bromide, followed by interaction of the 
enzyme with the activated dextran under appropriate 
conditions (cu-amylase, pH 9.0,4”C, 24 h; catalase, 
pH 8.0, 23”C, 20 h). After conjugation, traces of resi- 
dual unconjugated enzyme were removed from the 
products by gel chromatography on Sephadex G-100 
(ol-amylase) or Ultrogel AcA 34 (catalase), or by using 
concanavalin A-Sepharose [ 1 l] . The relative amounts 
of carbohydrate and protein in both conjugate prepa- 
rations, on a weight basis, were nominally 10 : 1. The 
conjugated enzyme preparations had specific activities 
of 170 U/mg (a-amylase) and 12 000 U/mg (catalase) 
compared with the specific activities of the correspond- 
ing native enzymes which were 400 U/mg and 
17 000 U/mg, respectively. 
3. Results and discussion 
To investigate the circulatory lifetime of cu-amylase 
the native and conjugated forms of the enzyme were 
administered to rats; in these animals the level of 
circulatory a-amylase is low and it has a different pH 
optimum than does the bacterial enzyme, allowing 
specific determination of the administered enzyme 
without difficulty. Catalase could not conveniently 
be tested in rats because of the high endogenous blood 
catalase levels; resort was therefore made to using 
acatalasemic mice in which blood catalase levels are 
very low [ 121 . 
Samples of native and conjugated Bacillus amylo- 
liquefaciens cu-amylase (approx. 400 U a-amylase 
activity; 1 mg protein in the case of native enzyme and 
2.5 mg protein in the case of the conjugated enzyme) 
were administered to rats (av. wt approx. 200 g) via 
their tail veins. Blood samples were removed from the 
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tail veins of the animals at intervals over the period of 
2 h and assayed for bacterial a-amylase activity. A 
similar procedure was followed in the case of catalase 
in the acalasemic mice; samples of native and conju- 
gated enzyme (approx. 12 000 U catalase; 0.7 mg 
protein in the case of native enzyme and 1 mg protein 
in the case of conjugated enzyme were administered 
to the animals (av. wt approx. 30 g) via their tail veins 
and catalase levels in blood samples removed from the 
animals over the period of 2 h were measured. In addi- 
tion, the catalase-dextran conjugate and native 
catalase (approx. 50 000 U catalase; 3 mg or 4 mg 
enzyme protein) were administered intraperitoneally 
to acatalasemic mice, followed by measurement of 
blood catalase levels over the period of 24 h. 
Injection of both native enzymes and their dextran 
conjugates directly into the circulation of the experi- 
mental animals resulted in initially high blood enzyme 
levels, which decreased with time. However, the 
conjugated enzymes were, in both cases, removed at 
markedly lower rates than were the native enzymes. 
Thus 2 h after injection into rats, 75% of the conju- 
gated ol-amylase remained in the blood, but only 16% 
of the native enzyme was still present in the circula- 
tion (fig.1). Conjugated catalase also had a much 
Fig.1. Removal of Bacillus amyloliquefaciens a-amylase from 
the circulation of rats after intravenous administration of 
native enzyme (o) or cu-amylase-dextran conjugate (e). In 
both cases 400 U amylase activity (1 mg protein in the case 
of native amylase and 2.5 mg protein in the case of conju- 
gated amylase) were injected. The average values and ranges 
for groups of three rats are shown. 
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Fig.2. Removal of bovine liver catalase from the circulation 
of acatalasemic mice after intravenous administration of native 
enzyme (o), or catalase-dextran conjugate (0). In both cases 
12 000 U catalase activity (approx. 1 mg protein) were 
injected. The average values and ranges for groups of four 
mice are shown. 
greater circulatory lifetime than did the native enzyme. 
60 min after intravenous administration to acatalase- 
mic mice, 93% of the native enzyme had been removed, 
whereas the level of conjugated enzyme activity fell 
by less than 30% in the same time (fig.2). The half-lives 
of native and conjugated catalase were 17 min and 
140 min. When injected intraperitoneally into acatalase- 
mic mice, native catalase appeared in the blood 
stream rapidly, maximum activity levels being reached 
2 h after injection, compared with the 4.5 h required 
to attain maximum blood catalase levels following 
intraperitoneal injection of the catalase-dextran 
conjugate. Following delivery by the intraperitoneal 
route, the maximum blood catalase level obtained 
with the conjugated enzyme was three times higher 
than that reached with native enzyme; the blood 
catalase level returned to normal within 4.5 h of 
injection of native enzyme but 22 h after administra- 
tion of conjugated catalase the enzyme was still 
present at a level of 33% of the maximum level 
attained. 
We have shown previously that conjugation of 
enzymes with dextran produces extremely high 
molecular weight aggregates containing many enzyme 
molecules and many dextran molecules, linked both 
intermolecularly and intramolecularly [3] . Thus, the 
decreased rate of passage of catalase from the perito- 
neal cavity into the circulation following conjugation 
with dextran would be expected simply on a molec- 
ular weight basis. What could not have been predicted 
with certainty was the finding that carbohydrate 
attachment extends the lifetimes of the enzymes in 
the circulation. Removal of proteins and glyco- 
proteins from the circulation can take place by a 
number of mechanisms, including excretion in the 
urine, specific uptake from the blood by interaction 
of structural features in the macromolecules with 
cell-surface receptors, and non-specific uptake by the 
reticuloendothelial system, particularly the spleen 
and the Kupffer cells of the liver. The susceptibility 
of a protein to clearance in these different ways is 
likely to depend on its molecular properties such as 
structure, charge and molecular weight [ 131 . In the 
case of a-amylase there is substantial excretion of 
the native enzyme in the urine, suggesting that the 
increased circulatory lifetime is the result of decreased 
susceptibility of the conjugated enzyme to clearance 
by urinary excretion consequent to the increase in 
molecular weight caused by conjugation. In the case 
of catalase, however, which in its native form has a 
molecular weight outside the range of susceptibility 
to glomerular filtration, this effect is unlikely to be 
involved and some alternative explanation must be 
invoked to explain the increased circulatory lifetime. 
On the basis of molecular weight alone, a faster rate 
of clearance of the conjugated enzyme from the 
circulation might have been anticipated, because of 
increased susceptibility of the conjugate to be uptaken 
by the reticuloendothelial system [ 131 . However, 
previous studies [ 141 have indicated a relationship 
between the plasma half-life of a protein and its 
isoelectric point, the half-life increasing as the iso- 
electric point decreases, in accordance with other 
indications that uptake by cells of macromolecules 
is favored by their having cationic properties [ 131 . 
The same phenomenon may be involved in the 
present case, since conjugation of enzymes with 
cyanogen bromide-activated dextran results in a 
modification of surface lysine residues, presumably 
accompanied by a decrease in isoelectric point. An 
additional factor that may be involved in prolonging 
the circulatory lifetime of the modified enzymes is 
the effect of the attached carbohydrate chains serving 
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to ‘disguise’ the enzymes making them more compat- 
ible with the vascular system, less susceptible to the 
action of proteolytic enzymes, and preventing their 
recognition and uptake by the reticuloendothelial 
system. Further studies are in progress to investigate 
in detail the relative importance of molecular weight 
and charge properties of conjugated enzymes and the 
structure of the carbohydrate component in deter- 
mining the circulatory lifetimes of enzyme-carbo- 
hydrate conjugates. 
Extension of the circulatory lifetimes of proteins 
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